A

Apellis Pharma (APLS)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Apellis Pharma (APLS)

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit ... Read more

Open
USD19.01
High
USD19.15
Low
USD18.63
52 Week High
USD43.15
Monthly Return
9.90%
Revenue
776M

Daily Vol.
292.31k
Avg. Daily Vol.
2.32M
Market Cap.
2.4B
52 Week Low
16.10
Annual Return
-54.70%

Stock News

You can still find hot tech stocks as a value investor — if you take this approach

You can still find hot tech stocks as a value investor — if you take this approach

MarketWatch

Here's the No. 1 phrase dads 'hate hearing' on Father's Day, says parenting expert—what to say instead

Here's the No. 1 phrase dads 'hate hearing' on Father's Day, says parenting expert—what to say instead

CNBC

Novo Nordisk ramps up obesity fight, advances amycretin to Phase III

Novo Nordisk ramps up obesity fight, advances amycretin to Phase III

Yahoo

I Am Swimming In Dividends With +7% Yields

I Am Swimming In Dividends With +7% Yields

SeekingAlpha

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.